Benchmark Holdings, the former parent company of Norwegian fish genetics company Benchmark Genetics, is planning to re-register as a private company following the sale.
Benchmark Holdings announced on 25 November 2024 that it was planning to sell the genetics arm of the business to Novo Holdings’ subsidiary Starfish Bidco for an enterprise value of GBP 260 million (USD 350 million, EUR 309 million). In late March, the company announced that the transaction had been successfully completed, which eventually resulted in gross cash proceeds of GBP 194 million (USD 261 million, EUR 231 million).
In an announcement to the Oslo Børs, Benchmark Holdings said the company has since been “assessing how best to return excess capital to shareholders and position the remaining operating businesses for future growth.”
To do that, it is proposing to ...
